Evidence map›Paper›PMID 26464136›Full record

ArticleCMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne2016

North American regulatory agencies can and should make clinical trial data publicly available.

Nav Persaud, Peter Doshi

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Considering benefits and harms of duloxetine for treatment of stress urinary incontinence: a meta-analysis of clinical study reports.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2017
    Pooled it
  2. Article
  3. Article
  4. Increasing the transparency of clinical data.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2017
    Article
  5. Secrecy or transparency? The future of regulatory trial data.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Nav PersaudDepartment of Family and Community Medicine (Persaud) and Li Ka Shing Knowledge Institute (Persaud), St. Michael's Hospital, Toronto, Ont.; Department of Family and Community Medicine (Persaud), University of Toronto, Toronto, Ont.; Department of Pharmaceutical Health Services Research (Doshi), School of Pharmacy, University of Maryland, Baltimore, Md. nav.persaud@utoronto.ca.
Peter DoshiDepartment of Family and Community Medicine (Persaud) and Li Ka Shing Knowledge Institute (Persaud), St. Michael's Hospital, Toronto, Ont.; Department of Family and Community Medicine (Persaud), University of Toronto, Toronto, Ont.; Department of Pharmaceutical Health Services Research (Doshi), School of Pharmacy, University of Maryland, Baltimore, Md.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Government RegulationClinical Trials as TopicDisclosureInformation DisseminationNorth America

Identifiers

PMID26464136
PMCPMC4732955

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.